This month’s Manufacturing Medicines Industry Partnership (MMIP) conference – Propelling growth: taking the next step in innovative medicines manufacturing – took place at an exciting time for the pharma industry. Advanced therapies (ATs) – such as cell therapies in which patients are treated with living cells – have been under development for…
Light has become a powerful medical tool. Continuing advances in the understanding of biological interactions with light, and newly developing light technologies, have given rise to a wide range of light-based therapies. As a physicist, I use light to study and modify the properties of materials down to the nanoscale.…
The rise of connected devices and the variety of information they can generate is set to drive an increase in patient adherence to therapies. Our trials have shown that remote and hidden sensing of actual user behaviour can uncover unexpected and significant opportunities to improve the patient experience.So how can…
Head of medical therapy systems Matt Brady has been appointed a partner at technology and product design firm Cambridge Design Partnership (CDP). The move is the latest phase of the company’s expansion in the healthcare sector and comes just weeks after the appointment of industry veteran Bastiaan de Leeuw to…
Technology and product design firm Cambridge Design Partnership (CDP) has announced the appointment of drug delivery industry veteran Bastiaan de Leeuw as it embarks on a new phase of growth in the sector. As head of drug delivery business development, he will be driving CDP’s expansion into new markets around…
6 November 2017 – A new approach to drug delivery device development is set to transform the experience of patients who face the challenge of regularly injecting themselves as part of their treatment for chronic diseases such as rheumatoid arthritis (RA). Technology and product design firm Cambridge Design Partnership (CDP) has…
18 October 2017 – Help is on the horizon for patients juggling complicated treatment regimens for chronic diseases such as rheumatoid arthritis (RA). A novel approach to drug delivery from technology and product design firm Cambridge Design Partnership (CDP) is paving the way for a new generation of treatment that…
Diagnostic testing is rapidly moving out of the lab and into the hands of untrained users. But developing the system architecture for ahigh-performance test that is also easy to use is a complex challenge.A great example of advancements in point-of-care (PoC) testing is the pregnancy test. In the 1970s, Wampole’s…
Last month I had the opportunity to spend the week in the South of France. But instead of catching up on some much needed Vitamin D, I joined other industry experts in the world of Respiratory Drug Delivery (RDD) at the 2017 conference in Nice. One of the main themes running…
Reflections on two themes from the day; – Usability: Continuity from marketing, through R&D, to regulatory– Connected devices and systems: Realising the benefits Usability: Continuity from marketing, through R&D, to regulatoryWe were struck by the frequency at which we heard terms like “usability,” “workflow” and “seamless integration” during presentations on…
Meet the team at Cambridge Design Partnership – a brief profile of the experts, engineers and interesting people that work here. This month we’re talking to Caroline Zakrzewski, a drug delivery devices expert.1. Why did you join Cambridge Design Partnership?I’ve been very lucky in my career to have worked on…
It’s important to realise that beyond the realm of classical engineering principles lays the softer, squishier world of biology and medicine. By being intimately familiar with human anatomy, biomedical engineers are able to more rapidly question whether their concepts are truly viable prior to embarking on further development, using an…